| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.1M | +20.8% | +47.3% |
| Cost of Revenue | $10.9M | +30.9% | +55.0% |
| R&D Expense | $4.5M | -20.9% | +51.5% |
| SG&A Expense | $5.9M | -26.2% | -65.0% |
| Operating Income | -$7.6M | +31.9% | +57.4% |
| Pre-tax Income | -$7.8M | +30.2% | +53.7% |
| Income Tax | $0 | — | — |
| Net Income | -$7.8M | +30.2% | +53.7% |
| EPS (Basic) | -$0.05 | +28.6% | +54.5% |
| EPS (Diluted) | -$0.05 | +28.6% | +54.5% |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $46.7M | -20.4% | -46.6% |
| Accounts Receivable | $11.6M | -7.6% | -9.1% |
| Inventory | $18.2M | -6.4% | +55.2% |
| Current Assets | $93.4M | -16.3% | -45.3% |
| Total Assets | $155.0M | -11.0% | -32.8% |
| Current Liabilities | $38.5M |
| Line Item | 2025-06-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.2M | -129.3% | — |
| Capital Expenditures | $77K | — | — |
| Investing Cash Flow | $476K | +150.9% | — |
| Financing Cash Flow | -$556K | -149.3% | — |
| Free Cash Flow | -$23.3M | -130.1% | — |
| -36.1% |
| Long-term Debt | $5.3M | -5.8% | — |
| Total Liabilities | $62.7M | -15.2% | -28.7% |
| Stockholders' Equity | $92.3M | -7.9% | -35.3% |